GENFF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 8 closing price
Capitalization
13.27M
Intraday BUY SELL Signals
OCS
Price
$23.84
Change
+$0.18 (+0.76%)
Updated
Jan 15 closing price
Capitalization
1.38B
Intraday BUY SELL Signals
Interact to see
Advertisement

GENFF vs OCS

Header iconGENFF vs OCS Comparison
Open Charts GENFF vs OCSBanner chart's image
Genflow Biosciences
Price$0.03
Change-$0.00 (-0.00%)
Volume$152K
Capitalization13.27M
Oculis Holding AG
Price$23.84
Change+$0.18 (+0.76%)
Volume$253.82K
Capitalization1.38B
GENFF vs OCS Comparison Chart in %
GENFF
Daily Signal:
Gain/Loss:
OCS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GENFF vs. OCS commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GENFF is a Hold and OCS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (GENFF: $0.03 vs. OCS: $23.84)
Brand notoriety: GENFF and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GENFF: 191% vs. OCS: 186%
Market capitalization -- GENFF: $13.27M vs. OCS: $1.38B
GENFF [@Biotechnology] is valued at $13.27M. OCS’s [@Biotechnology] market capitalization is $1.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GENFF’s FA Score shows that 0 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • GENFF’s FA Score: 0 green, 5 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, GENFF is a better buy in the long-term than OCS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GENFF’s TA Score shows that 3 TA indicator(s) are bullish while OCS’s TA Score has 6 bullish TA indicator(s).

  • GENFF’s TA Score: 3 bullish, 3 bearish.
  • OCS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OCS is a better buy in the short-term than GENFF.

Price Growth

GENFF (@Biotechnology) experienced а 0.00% price change this week, while OCS (@Biotechnology) price change was +8.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +41.99%.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($1.38B) has a higher market cap than GENFF($13.3M). OCS YTD gains are higher at: 19.379 vs. GENFF (-4.667).
GENFFOCSGENFF / OCS
Capitalization13.3M1.38B1%
EBITDAN/A-102.99M-
Gain YTD-4.66719.379-24%
P/E RatioN/A63.08-
RevenueN/A0-
Total CashN/A145M-
Total DebtN/A2.47M-
TECHNICAL ANALYSIS
Technical Analysis
GENFFOCS
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
46%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
41%
Momentum
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 3 days ago
55%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 3 days ago
55%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
69%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
63%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
41%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
GENFF
Daily Signal:
Gain/Loss:
OCS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REX33.740.34
+1.02%
REX American Resources Corp
NEN65.25N/A
N/A
New England Realty Associates Limited
HHS3.04N/A
N/A
Harte Hanks
KMI27.41-0.12
-0.44%
Kinder Morgan
MTN139.17-3.44
-2.41%
Vail Resorts

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and TOVX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and TOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
TOVX - GENFF
25%
Poorly correlated
+3.24%
VRCA - GENFF
23%
Poorly correlated
-4.28%
SGMT - GENFF
10%
Poorly correlated
-1.73%
OCS - GENFF
6%
Poorly correlated
+0.76%
APGE - GENFF
3%
Poorly correlated
-2.04%
More

OCS and

Correlation & Price change

A.I.dvisor tells us that OCS and SNSE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OCS and SNSE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
+0.76%
SNSE - OCS
32%
Poorly correlated
-3.09%
CGON - OCS
30%
Poorly correlated
-4.40%
GRI - OCS
30%
Poorly correlated
+1.22%
PRAX - OCS
29%
Poorly correlated
-0.24%
CGEN - OCS
28%
Poorly correlated
+6.57%
More